Pharmaceutical industry in China

Pharmaceuticals in shortage being exported by wholesalers – New complaints from pharmacists

The “war” between pharmacists and wholesalers over the ongoing medication shortages in the Greek market seems unending. The PFS has shared a letter from a private wholesaler to cooperative wholesalers, accompanied by a list of products intended for export.

Novartis comes under scrutiny over competition rules

The Competition Commission is investigating pharmaceuticals firm Novartis for anti-competitive practices from 2009 to 2017.

The probe concerns a range of competitive medicines treating macular diseases.

A report found Novartis aimed to prevent market access to competitors.

The commission will consider the report findings at a December 4 meeting. 

Serbian gov't signs MoU with pharmaceuticals company MSD

BELGRADE - Serbian PM Ana Brnabic and the senior vice president of the pharmaceuticals firm Merck Sharp and Dohme (MSD), Cyril Schiever, signed on Wednesday a MoU that will be significant for Serbia's future BIO4 Campus research centre.

Brnabic thanked MSD for supporting "our efforts to make Serbia a leader in biotechnology, biomedicine, bioresearch and bioinformatics."

Labena Ventures to foster biotech, pharmacy and healthcare ideas

Labena, a Ljubljana-based family-run business, is launching a new platform to link start-up companies and disruptive ideas with venture capital and investment funds in medicine, biotechnology and the food and pharmaceutical industries. More than €100 million will be available, with applications expected from 14 March.

Health minister, manufacturers meet to review drugs shortages

The Greek agency for pharmaceuticals (EOF), wholesalers, pharmacies and others met on Monday with Health Minister Thanos Plevris to review the issue of lack of drug availability in the Greek market.

While all cited global issues in medicine shortages, they also said the issue was not as severe as in other countries since Greece has its own production of pharmaceuticals as well.

Antibiotice's business turnover advances 11pct in H1 2021

The Iasi-based Antibiotice pharmaceuticals company has reported an H1 2021 business turnover of 163.39 million lei, up 11% from 2020, according to a company's press statement released on Monday. From its H1 2021 revenues, the company paid the public healthcare system 13.5 million lei in the clawback tax, which influenced the profitability rate.

Romanian pharma industry's turnover close to 70 bln lei this year

The turnover of Romanian drug manufacturers, distributors and pharmacies was 66.6 billion lei in 2020, up 2.6 percent from 2019 and over 100 percent higher compared to 2010, shows a survey by KeysFin - one of the most important providers of business information solutions in Romania - based on Finance Ministry figures.

Pages